Alkermes plc. Income Taxes Paid
Alkermes plc. (ALKS) reported Income Taxes Paid of $5.24 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-02-25
- Alkermes plc. income taxes paid for the quarter ending 2013-03-31 was $2.79M.
- Alkermes plc. income taxes paid for the quarter ending 2012-12-31 was $958.00K, a 90.47% decline year-over-year.
- Alkermes plc. income taxes paid for the quarter ending 2012-09-30 was $1.27M, a 31600.00% increase year-over-year.
- Alkermes plc. income taxes paid for the quarter ending 2012-06-30 was $909.00K, a 8163.64% increase year-over-year.
- Alkermes plc. income taxes paid for fiscal 2025 was $5.24M, a 102.04% increase from fiscal 2024.
- Alkermes plc. income taxes paid for fiscal 2024 was $2.59M, a 94.14% decline from fiscal 2023.
- Alkermes plc. income taxes paid for fiscal 2023 was $44.24M, a 113.23% increase from fiscal 2022.
- Alkermes plc. income taxes paid for fiscal 2022 was $20.75M, a 998.99% increase from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.24M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $2.59M 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $44.24M 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $20.75M 10-K · filed 2025-02-12 | |||
| 2021-12-31 | $1.89M 10-K · filed 2024-02-21 | |||
| 2020-12-31 | $620.00K 10-K · filed 2023-02-16 | |||
| 2019-12-31 | $2.51M 10-K · filed 2022-02-16 | |||
| 2018-12-31 | $754.00K 10-K · filed 2021-02-11 | |||
| 2017-12-31 | $2.99M 10-K · filed 2020-02-13 | |||
| 2016-12-31 | $5.53M 10-K · filed 2019-02-15 | |||
| 2015-12-31 | $705.00K 10-K · filed 2018-02-16 | |||
| 2014-12-31 | $2.80M 10-K · filed 2017-02-17 | |||
| 2013-12-31 | $704.00K 10-K · filed 2016-02-25 | |||
| 2013-03-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $3.74M derived: sum of 2 quarters · filed 2015-02-24 | $5.01M derived: sum of 3 quarters · filed 2015-02-24 | $5.92M 10-K · filed 2015-02-24 |
| 2012-12-31 | $958.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $2.23M derived: sum of 2 quarters · filed 2013-01-31 | $3.13M 10-Q · filed 2013-01-31 | $3.13M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-09-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-01 | $2.18M 10-Q · filed 2012-11-01 | $2.17M derived: sum of 3 quarters · filed 2014-02-27 | $12.23M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $909.00K 10-Q · filed 2012-07-26 | $907.00K derived: sum of 2 quarters · filed 2014-02-27 | $10.96M derived: sum of 3 quarters · filed 2014-02-27 | $10.97M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$2.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | $10.05M derived: sum of 2 quarters · filed 2014-02-27 | $10.06M derived: sum of 3 quarters · filed 2014-02-27 | $10.07M 10-KT · filed 2014-02-27 |
| 2011-12-31 | $10.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $10.06M derived: sum of 2 quarters · filed 2013-01-31 | $10.07M 10-Q · filed 2013-01-31 | |
| 2011-09-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-01 | $15.00K 10-Q · filed 2012-11-01 | ||
| 2011-06-30 | $11.00K 10-Q · filed 2012-07-26 | |||
| 2011-03-31 | $60.00K 10-K · filed 2013-05-23 | |||
| 2010-03-31 | $114.00K 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |